HB 543 2022
CODING: Words stricken are deletions; words underlined are additions.
hb0543-00
Page 1 of 3
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
A bill to be entitled 1
An act relating to uterine fibroid research and 2
education; creating s. 381.9312, F.S.; providing 3
definitions; requiring the Department of Health to 4
develop and maintain an electronic database of 5
information related to uterine fibroids; providing a 6
specified purpose for such database; requiring that 7
the database include specified information; requiring 8
health care providers to submit certain information to 9
the department for inclusion in the database; 10
prohibiting the database from including any personal 11
identifying information; providing that such 12
information is confidential; authorizing certain 13
persons to use such information for a specified 14
purpose; requiring the department, in consultation 15
with the Florida Medical Association, to develop and 16
disseminate certain information to educate health care 17
providers and conduct a public awareness campaign; 18
providing an effective date. 19
20
Be It Enacted by the Legislature o f the State of Florida: 21
22
Section 1. Section 381.9312, Florida Statutes, is created 23
to read: 24
381.9312 Uterine fibroid research database; education and 25
HB 543 2022
CODING: Words stricken are deletions; words underlined are additions.
hb0543-00
Page 2 of 3
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
public awareness.— 26
(1) DEFINITIONS.—As used in this section, the term: 27
(a) "Department" means th e Department of Health. 28
(b) "Health care provider" means a physician licensed 29
under chapter 458 or an advanced practice registered nurse 30
registered under s. 464.0123. 31
(c) "Uterine fibroid" means a noncancerous growth of the 32
uterus that often appears du ring a woman's childbearing years. 33
(2) UTERINE FIBROID RESEARCH DATABASE. — 34
(a) The department shall develop and maintain an 35
electronic database consisting of information related to uterine 36
fibroids. The purpose of the database is to encourage research 37
relating to the diagnosis and treatment of uterine fibroids and 38
ensure that women are provided with the relevant information and 39
health care necessary to prevent and treat uterine fibroids. The 40
database must include, but need not be limited to, all of the 41
following information: 42
1. Incidence and prevalence of women diagnosed with 43
uterine fibroids in the state. 44
2. Demographic attributes of women diagnosed with uterine 45
fibroids in the state. 46
3. Treatments and procedures for uterine fibroids used by 47
health care providers in the state. 48
(b) A health care provider who diagnoses or treats a woman 49
with uterine fibroids shall submit information relating to such 50
HB 543 2022
CODING: Words stricken are deletions; words underlined are additions.
hb0543-00
Page 3 of 3
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
diagnosis or treatment to the department in a form and manner 51
prescribed by department rule for incl usion in the database. 52
Such information may be submitted along with any reports or 53
other information that the health care provider is required to 54
submit to the department pursuant to state law. 55
(c) The database may not include any personal identifying 56
information of women diagnosed with or treated for uterine 57
fibroids. Such information is confidential and may be used only 58
by employees or agents of the department for the purpose of 59
conducting uterine fibroid research. 60
(3) UTERINE FIBROID EDUCATION OUTR EACH AND PUBLIC 61
AWARENESS.—The department, in consultation with the Florida 62
Medical Association, shall develop and disseminate information 63
related to uterine fibroids to educate health care providers and 64
conduct a campaign to increase public awareness of u terine 65
fibroids which must include, but need not be limited to, all of 66
the following: 67
(a) Possible risk factors for developing uterine fibroids, 68
including, but not limited to, the races or ethnicities of women 69
who have a statistically elevated risk of de veloping uterine 70
fibroids. 71
(b) Range of available treatment options for uterine 72
fibroids, including, but not limited to, treatments and 73
procedures that are considered alternatives to hysterectomy. 74
Section 2. This act shall take effect July 1, 2022. 75